1 |
Shao C, Xu L, Lei P, Wang W, Feng S, Ye J, Zhong B. Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease. J Transl Med 2023;21:12. [PMID: 36624524 DOI: 10.1186/s12967-022-03760-6] [Reference Citation Analysis]
|
2 |
Gangopadhyay A, Ibrahim R, Theberge K, May M, Houseknecht KL. Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines. Front Neurosci 2022;16. [DOI: 10.3389/fnins.2022.1042442] [Reference Citation Analysis]
|
3 |
Dong Y, Zhang Y, Feng Y, An W. The protective roles of augmenter of liver regeneration in hepatocytes in the non-alcoholic fatty liver disease. Front Pharmacol 2022;13:928606. [DOI: 10.3389/fphar.2022.928606] [Reference Citation Analysis]
|
4 |
Khan A, Ross HM, Parra NS, Chen SL, Chauhan K, Wang M, Yan B, Magagna J, Beiriger J, Shah Y, Shahzad T, Halegoua-demarzio D. Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD). Livers 2022;2:264-282. [DOI: 10.3390/livers2040022] [Reference Citation Analysis]
|
5 |
Leone A, Bertoli S, Bedogni G, Vignati L, Pellizzari M, Battezzati A. Association between Mediterranean Diet and Fatty Liver in Women with Overweight and Obesity. Nutrients 2022;14:3771. [DOI: 10.3390/nu14183771] [Reference Citation Analysis]
|
6 |
Arredouani A. Effectiveness of Lifestyle Interventions for Nonalcoholic Fatty Liver Disease Treatment. Lifestyle-Related Diseases and Metabolic Syndrome [Working Title] 2022. [DOI: 10.5772/intechopen.106445] [Reference Citation Analysis]
|